Ms Niamh Hynes, MD MRSC

Ms Niamh Hynes is a director and co-founder of the Western Vascular Institute (WVI). Ms Niamh Hynes is a Vascular & Endovascular Surgical Registrar at the Galway Clinic and has over 12 years experience in Vascular clinical practice. Ms Hynes is a Clinical Lecturer in Endovascular Surgery at the National University of Ireland Galway (NUIG),  teaching undergraduate students ,and co-supervising PhD researchers in Bio-engineering. Additionally, Ms Hynes trains future specialists on clinical and academic aspects of surgery in the MMSc Endovascular Clinical Fellowship.

Recently Ms Hynes has become an Science Foundation Ireland Principal Investigator and leads an exciting new joint CÚRAM-Boston Scientific research project.

In terms of clinical research has an H index of 21, Citations 1649, i10 index 42 due to 100 Peer-reviewed scientific papers (7 first author, 32 senior author), 9 book chapters, 165 abstract publications., 88 first author oral presentations at international conferences, 22 first author oral presentations at national conferences and 111 first author poster presentations. Ms Hynes has received 18 international awards.

The National Institute of Health in the USA cited her publication on cost-effectiveness of endovascular aortic repair as one of the most ground-breaking in this field in the last decade.

Ms Hynes spent 4 years in full time research at NUI Galway, 2 years undertaking a Masters of Medical Science (MMSc) and 2 years for my MD higher degree, at REMEDI. She completed her MD higher degree on microarray analysis of in-stent restenosis in Metabolic Syndrome, having established a dedicated and unique endovascular carotid stenting model in the Zucker rat.

Ms Hynes leads a Cochrane Review team within the WVI, which has six active reviews with the Cochrane Vascular and Stroke Groups, in collaboration with Prof Declan Devane at the HRB Trials Methodology Research Network (TMRN). As team leader, Ms Hynes has a 100% success rate in directing submissions for reviews on aortic aneurysm, aortic and carotid dissection, and critical limb ischaemia. In 2016, a member of the team, Dr Ala Elhelali, was awarded a HRB Cochrane Fellowship.

Ms Hynes is an investigator in international endovascular device trials, including INSIGHT (Cardinal Health), and Enchant (Medtronic) trials, and founded the Multilayer Flow Modulater Global Regisrty in 2014, which retrospectively observes clinical outcomes of the MFM device. Ms Hynes was a co-applicant on a successful Enterprise Ireland commercialisation fund worth €400,000 to develop a percutaneous carotid artery sheath and closure device at NUI Galway. Ms Hynes also has a published patent for an endovascular delivery device, which won an Enterprise Ireland Cleveland Clinical Innovation Award in 2014, and has since filed further patents for wide bore
femoral closure and structural heart devices.